Restoring trust in audit and corporate governance

whitePaper | January 21, 2020

When America’s Founders wrote the Constitution, they laid out a clear vision for the United States Government: to establish justice, ensure domestic tranquility, provide for the common defense, promote the general welfare, and secure the blessings of liberty. Moreover, they established Executive Branch organizations and structures to deliver on the Federal mission in ways appropriate to America’s needs at the time. Over successive generations, our Federal Government has evolved by expanding in scope and complexity to try to meet Americans’ needs. However, the organizational structures that underpin the Executive Branch have not always kept pace.

whitePaper | January 17, 2023

Digital modernization refers to the process of utilizing technology, whether through adoption of new tools or the improvement of existing ones, to achieve organizational goals. This can include enhancing the user experience, ensuring high uptime, implementing robust security measures, reducing latency, and streamlining processes for resolving issues. All levels of government are going through a digital transformation to deliver services and programs more effectively,transparently, and economically.To meet the demands of citizens who have adapted to the technological advancements in society, digital government transformation has become a vital aspect of providing efficient and effective services. However, one of the biggest hurdles in this process for federal agencies is striking a balance between leveraging technology for its benefits and maintaining robust security and privacy measures. Federal agencies handle confidential information regularly, making it imperative to safeguard against data breaches. Consequently, agencies must ensure that their digital systems and procedures are secure and adhere to relevant regulatory requirements.

whitePaper | April 30, 2022

NeoTech is creating smart city digital infrastructure that can lead to massive improvements in citizens quality of life and increase the protection of the environment while reducing the cost of doing so. NeoTech uses cutting edge technology in both hardware and software to recreate a 1:1 exact replica of the Earth in utterly digital form, enabling thousands of new applications to be spun off on top of our new Metaverse, enabling startups, enterprises, and people alike to take part in this new technological revolution.

whitePaper | March 15, 2023

How Federal Agencies leverage data for decision making is changing. Historical transaction reporting and static batch data analyses are giving way to predictive data science, streaming analytics, machine learning (ML), and artificial intelligence (AI). Agencies are embracing these new paradigms for more informed, real-time decisions to impact business, operations, and agency performance.

whitePaper | July 18, 2022

The world is more peaceful, safe, and prosperous when the human rights of women are respected and they can fully participate in economic, social, and political life. But we know the enduring challenges of fulfilling that promise. A defining competition between democracies and autocracies. The COVID-19 pandemic. The climate crisis. Mass migration and displacement. The denial of education and sexual violence against women and girls across the world. No matter what global crisis unfolds—women and girls are disproportionately impacted, and that makes the world less stable.

whitePaper | December 10, 2019

The Trump administration, members of Congress from both parties, and many states have introduced proposals to combat high drug prices. Too often missing from these reform efforts, however, is a clear understanding of a root cause of the crisis: the suppression of fair market competition through various forms of monopoly. This white paper examines and proposes solutions for the two main ways that monopoly drives up the costs and lowers the quality of prescription drugs: increasing corporate concentration in the pharmaceutical industry, and the monopoly markets for individual drugs created by a deeply flawed and increasingly abused patent and regulatory system.